I think that's clearly what happened. you just have to look at what was happening to Sarepta at the time. Something about toxicity (probably due to high volume of product delivered), less than expected effectiveness and SP halving...Sarepta were in damage control. their loss. Now it seems Audentes have a couple of drugs targeting DMD in their pipeline. its hotting up. Imagine if PYCtx were able to deliver Sarepta's DMD drug (far)more effectively to eliminate/reduce toxicity - that would wake them up.
Ann: Drug Delivery Greater Than 100% More Effective In Animals, page-35
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204320 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4333 | 2 |
View Market Depth
| Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |